Fig. 4From: Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugsSurvival curves and reconstructed IPD of pembrolizumab, a is reproduced Kaplan–Meier curves and fitted survival curves, b is first-reconstructed IPD, c is adjusted mature survival curves and d is second-reconstructed IPDBack to article page